- Poland joins the elite, the most developed countries that have already covered a significant portion of the population with HPV vaccination, stresses Professor Andrzej Nowakowski of the Maria Sklodowska-Curie National Institute of Oncology. He adds that the vaccines have been thoroughly tested, reduce the risk of cancers caused by these viruses and do not cause any late post-vaccination reactions or any negative health effects.
The HPV vaccines used in the universal vaccination program are the 2-valent Cervarix and the 9-valent Gardasil 9, with varying degrees of protection. The vaccination schedule for both vaccines is a two-dose schedule. The recommended interval between doses is 6 months. The parent has the right and opportunity to choose the vaccine and consult with the doctor. Both are well tolerated and safe. They are widely used in 125 countries.
A dangerous virus
Of the more than 200 types of human papillomavirus HPV, some are highly carcinogenic. HPV infection is primarily associated with cervical cancer, but also vu...